In rheumatoid arthritis (RA), adiponectin has been shown to promote the proliferation and differentiation of B cells by inducing the activation of the PI3K/Akt and activator of transcription 3 (STAT3) signaling pathways, exacerbating RA development (Che et al., 2021). Here, ADIPOQ is linked to rheumatoid arthritis.